Polyphenol modified gold nanorod with antigen capture capability and preparation and application thereof
By modifying phenolic acid compounds on the surface of gold nanorods, forming polyphenol-modified gold nanorods with antigen capture ability, the problems of tumor heterogeneity and limited photothermal therapy in antigen capture and immunotherapy are solved, and antigens are achieved Effective capture and activation of immune responses significantly improve tumor suppression and demonstrate good biocompatibility and safety.
Patent Information
- Application Number
- CN202411091790.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-09
AI Technical Summary
The prior art has problems of tumor heterogeneity and limited photothermal therapy in antigen capture and immunotherapy, resulting in inefficient rapid immune clearance and delivery of antigens and difficulty in effectively activate the immune response.
By modifying polyphenols on the surface of gold nanorods, phenolic acid compounds are used to connect amide bonds with HS-PEG-NH2 and EDCI/NHS to form polyphenol-modified gold nanorods with antigen capture ability, achieving effective capture of antigens and Immune cell activation.
Polyphenol-modified gold nanorods can induce immunogenic cell death in photothermal therapy, reduce rapid antigen immune clearance, improve immune response activation, significantly improve tumor suppression effect, and have good biocompatibility and safety.
Smart Images

Figure CN118987250A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of nano-biomedical materials and relates to a polyphenol-modified gold nanorod with antigen-capturing capability and the preparation and application thereof. Background Art
[0002] Immunotherapies such as cancer vaccines always revolve around the well-known cancer immunity cycle, which includes seven steps, the first of which is the release of tumor-associated antigens (TAAs). The released TAAs will be captured by antigen-presenting cells such as dendritic cells (DCs) and delivered to lymph nodes (LNs), and then activate T cells to kill tumor cells. However, existing problems such as the low immunogenicity of tumor vaccines and tumor heterogeneity will affect the efficacy of immunotherapy. Nanoformulations loaded with exogenous antigens are a traditional strategy to deliver more antigens to DCs. Many studies have shown that this strategy can enhance immunogenicity, but it cannot solve tumor heterogeneity because patient-specific TAAs are too unique and variable to be identified and separated in vitro. In contrast, capturing endogenous antigens seems to be an effective way to overcome tumor heterogeneity and is expected to improve the efficacy of immunotherapy.
[0003] Photothermal therapy (PTT) is widely used in clinical practice because it can convert skin-penetrating near-infrared light (NIR) into heat to ablate tumor tissue. This conversion depends on photothermal converters, including inorganic materials such as precious metals and carbon-based nanomaterials or organic materials such as near-infrared responsive small molecules and semiconductor polymer nanoparticles. Among them, gold nanorods (GNRs) are the preferred material for PTT, which has many advantages, including adjustable plasma wavelength in the NIR region, surface modification through gold thiol chemistry, and small particle size for lymph node targeting. In addition to directly killing tumor cells, experiments have shown that PTT also induces immunogenic cell death (ICD) effects, thereby releasing TAAs, including damage-associated molecular patterns (DAMPs), neoantigens, and proinflammatory cytokines. TAAs can induce DCs to mature and activate effector T cells, thereby triggering adaptive anti-tumor immune responses.
[0004] However, the immunotherapy effect of PTT alone is limited, partly because the antigens in the body are rapidly cleared by the immune system and the delivery efficiency is low, especially for metastatic tumors. Therefore, some studies have proposed the construction of in situ antigen capture nanoformulations to improve the utilization of TAAs. These preparations are mainly based on protein binding groups amino and maleimide to capture antigens, but the weak ionic interaction of amino groups may lead to poor protein binding ability, and the unique covalent thioether bond of maleimide may affect the protein structure and weaken the subsequent activation of immune response. Summary of the invention
[0005] In order to overcome the deficiencies of tumor heterogeneity and the limited nature of PTT treatment, the present invention aims to provide a polyphenol-modified gold nanorod with antigen capture capability and its preparation and application.
[0006] To achieve the above purpose, the technical solution adopted by the present invention is:
[0007] A method for preparing polyphenol-modified gold nanorods with antigen capture ability, wherein the polyphenol-modified gold nanorods are mainly composed of gold nanorods and are bonded to HS-PEG-NH 2 Ligand exchange is carried out, and then polyphenols are connected through amide bonds to obtain polyphenol-modified gold nanorods.
[0008] Specifically
[0009] (1) Ligand exchange of gold nanorods: preparation of HS-PEG-NH 2 The aqueous solution was slowly added into the gold nanorod solution, and stirred continuously in the dark. After the reaction was completed, the solution was fully centrifuged and resuspended in PBS buffer to obtain PEG-stabilized gold nanorods.
[0010] (2) Covalent attachment of polyphenols: Dissolve polyphenols, EDCI and NHS in MES buffer, stir under ice bath to activate the carboxyl groups on the polyphenols, then add them to the modified gold nanorods solution and stir at room temperature. After the reaction, centrifuge thoroughly and resuspend in PBS buffer to obtain polyphenol-modified gold nanorods.
[0011] The absorption peak of the gold nanorod is located in at least one of the visible light region, near infrared I region and near infrared II region, preferably in near infrared I region.
[0012] The gold nanorods are prepared by preparing gold seeds and a growth solution through a classic seed growth method, dripping the gold seed solution into the growth solution while stirring, incubating overnight in the dark, fully centrifuging after the reaction is completed, resuspending with deionized water, removing excess surfactant hexadecyltrimethylammonium bromide (CTAB) and other reactants, and obtaining a gold nanorod solution.
[0013] In step (1), HS-PEG-NH 2 The aqueous solution was mixed with the gold nanorod solution at a molar ratio of 200:1-20000:1, and reacted at room temperature for 12 hours. After the reaction, the mixture was fully centrifuged and resuspended with PBS buffer, and the process was repeated several times to remove the unreacted residues to obtain PEG-stabilized gold nanorods; wherein the centrifugation conditions were: 13000 rpm, 10 min;
[0014] The HS-PEG-NH 2 The connecting chain is HS-PEG 600 -NH 2 HS-PEG 2000 -NH2 HS-PEG 5000 -NH 2 HS-PEG 20000 -NH 2 One or more of the following, preferably HS-PEG 5000 -NH 2 .
[0015] In the step (2), polyphenols, EDCI and NHS are mixed and dissolved in a MES buffer at a molar ratio of 5:1:1-0.5:1:1; the pH of the MES buffer is 4.5-7.2, preferably 5.5; the molar ratio of gold nanorods to polyphenols is 1:200-1:20000, preferably 1:1000-1:5000.
[0016] The polyphenols are phenolic acid compounds, including caffeic acid, p-coumaric acid, ferulic acid, sinapinic acid, rosmarinic acid, 4-hydroxyphenylacetic acid, 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 3,4,5-trihydroxybenzoic acid and 3,4-dihydroxyphenylacetic acid.
[0017] A polyphenol-modified gold nanorod with antigen-capturing ability prepared by the method, wherein the polyphenol-modified gold nanorod with antigen-capturing ability prepared by the method has a long diameter of 30-40 nm and a short diameter of 3-4 nm, and a large number of polyphenols with protein-binding function are connected on the surface of the gold nanorod by PEG chains and are evenly dispersed.
[0018] A use of the polyphenol-modified gold nanorods with antigen-capturing ability in preparing a drug delivery system or an anti-tumor drug.
[0019] The beneficial effects of the present invention are as follows:
[0020] The polyphenol-modified gold nanorods with antigen capture capability of the present invention have surface ligand modification that does not affect the photothermal conversion capability of the gold nanorods. Photothermal therapy kills tumor cells while inducing the ICD effect to release TAAs. Antigens can be successfully captured by polyphenols on the surface of the gold nanorods, reducing rapid immune clearance, thereby further activating the immune system and greatly improving the tumor inhibition effect. Specifically:
[0021] (1) The polyphenol-modified gold nanorods of the present invention have excellent biocompatibility, and the synthesis method does not use organic solvents, which is simple, efficient and safe.
[0022] (2) The polyphenol-modified gold nanorods of the present invention retain the advantages of gold nanorods. The small particle size makes it easy to achieve lymph node targeting and the plasma wavelength can be controlled to achieve efficient photothermal conversion.
[0023] (3) The polyphenol-modified gold nanorods of the present invention can capture a large amount of antigens, activate immune cells, have good anti-tumor effects, and have good safety, with no obvious toxic side effects on mice.
[0024] (4) The polyphenols on the surface of the gold nanorods of the present invention can be used to capture various types of molecules, which is expected to achieve synergistic treatment of photothermal therapy with other therapies. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is a transmission electron microscope image of the gold nanorods in Example 1 of the present invention.
[0026] Figure 2 1 is the particle size and potential diagram of the gold nanorods in Example 1 of the present invention.
[0027] Figure 3 This is the UV-visible-near-infrared absorption spectrum of the gold nanorods in Example 1 of the present invention.
[0028] Figure 4 This is the Fourier infrared spectrum of the gold nanorods in Example 1 of the present invention.
[0029] Figure 5 This is a diagram of the in vitro photothermal effect of gold nanorods in Example 2 of the present invention.
[0030] Figure 6 This is a graph showing the in vitro cytotoxicity of gold nanorods in Example 3 of the present invention.
[0031] Figure 7 This is a confocal image of the in vitro photothermal ICD effect of gold nanorods in Example 4 of the present invention.
[0032] Figure 8 This is a diagram showing the in vitro antigen capture results of gold nanorods in Example 5 of the present invention.
[0033] Fig. 9 This is a diagram showing the results of in vitro BMDCs activation by antigen-coated gold nanorods in Example 6 of the present invention.
[0034] Fig.10 This is an immunofluorescence image of the in vivo photothermal ICD effect of gold nanorods in Example 7 of the present invention.
[0035] Fig.11 This is a flow cytometer graph of the activation of lymph node DCs in vivo by gold nanorods in Example 8 of the present invention.
[0036] Fig.12 This is a graph showing the changes in tumor volume in B16-F10 tumor-bearing mice in the in vivo efficacy test of the gold nanorods in Example 9 of the present invention.
[0037] Fig.13This is a graph showing the tumor-bearing rate of B16-F10 tumor-bearing mice in the in vivo efficacy test of the gold nanorods in Example 9 of the present invention.
[0038] Fig.14 This is a graph showing the weight changes of B16-F10 tumor-bearing mice in the in vivo efficacy test of the gold nanorods in Example 9 of the present invention.
[0039] Fig.15 This is a graph of blood indicators of B16-F10 tumor-bearing mice in the in vivo efficacy test of gold nanorods in Example 9 of the present invention.
[0040] Fig.16 This is a CD8 immunofluorescence image of tumor sections of B16-F10 tumor-bearing mice in the in vivo efficacy test of the gold nanorods in Example 9 of the present invention. DETAILED DESCRIPTION
[0041] The present invention will be further described below in conjunction with the embodiments and drawings, but the invention is not limited to the scope of the embodiments.
[0042] The polyphenol-modified gold nanorods of the present invention can capture antigens through non-covalent interactions. The polyphenol-modified gold nanorods have a small and uniform particle size, which is conducive to lymph node targeting. The surface-modified polyphenol end groups have strong protein binding ability. Surface ligand modification does not affect the photothermal conversion ability of the gold nanorods. Photothermal therapy successfully induces immunogenic cell death effects, synergizes in situ antigen capture, can effectively activate immune cells, inhibit tumor growth, and provide a new strategy for personalized tumor immunotherapy.
[0043] Example 1: Synthesis of polyphenol-modified gold nanorods
[0044] Synthesis of gold nanorods (GNR-CTAB): HAuCl 4 (50 μl, 10 mM) was mixed with CTAB (1 ml, 0.2 M), and then ice-cold NaBH 4 (120 μl, 10 mM), stirred vigorously for 2 minutes, and then the gold seed solution was placed at 25°C for 2 h. 4 (2 ml, 10 mM) and ascorbic acid 280 μl, 80 mM) were slowly added to CTAB (20 ml, 0.2 M) and AgNO 3 (0.8 ml, 4 mM) was added to the mixture while gently stirring to form a growth solution. Then 48 μl of the seed solution was added dropwise and reacted at 30 °C for 12 h. After the reaction, it was purified and concentrated by centrifugation (13000 rpm, 10 min), and washed three times with deionized water to remove the residual reactants to obtain GNRs suspended in water.
[0045] PEG-modified gold nanorods (GNR-NH 2):HS-PEG-NH 2 The aqueous solution (0.5 ml, 0.2 mM) was added to GNRs (1 ml, 2 nM), stirred for 12 h, and then washed three times by centrifugation (13000 rpm, 10 min) to obtain GNR-NH suspended in pH 7.4 PBS. 2 .
[0046] Synthesis of 3,4-dihydroxybenzoic acid-modified gold nanorods (GNR-PA) and 3,4,5-trihydroxybenzoic acid-modified gold nanorods (GNR-GA): EDCI / NHS / PA or EDCI / NHS / GA (molar ratio of 1:1:1) was dissolved in MES buffer (10 mM) at pH 5.5 and reacted at 4 °C for 2 h to activate the carboxyl groups. The above reaction solution (1 ml, 2 μM) was added dropwise to GNR-NH 2 (1 ml, 1 nM) for 2 h to conjugate GNR with PA or GA. The mixture was centrifuged (13000 rpm, 10 min) and washed three times to remove excess reactants, and the resulting GNR-PA or GNR-GA was resuspended in PBS (pH 7.4); thereby obtaining polyphenol-modified gold nanorods.
[0047] Transmission electron microscopy images of the four types of GNRs obtained above, including polyphenol-modified gold nanorods and other modified gold nanorods, are shown in Figure 2. Figure 1 As shown in Figure 2, surface modification did not affect the rod-like morphology of gold nanorods, and the distribution was uniform. Figure 2 As shown in the figure, the particle size increases slightly after surface modification. Since CTAB is a positively charged surfactant, the terminal amino group is positively charged after hydrolysis, and the phenolic hydroxyl group is negatively charged after hydrolysis, the GNRs have obvious potential changes during the modification process. Figure 3 As shown in Figure 1, the longitudinal plasma wavelength of the controlled GNRs is in the near-infrared I region, and the polyphenol-modified GNRs show a new absorption peak near the polyphenol absorption wavelength, indicating successful modification. Figure 4 As shown, the change in peak position and the appearance of amide bond marker peak indicate successful modification.
[0048] Example 2: Verification of the photothermal conversion capability of polyphenol-modified gold nanorods
[0049] PBS solution was used as a blank control to verify whether the GNRs with different modifications obtained in the above examples can generate heat after NIR laser irradiation. 0.5 ml of GNRs with different concentrations (10, 20, and 40 μg / ml) was added to a centrifuge tube, and NIR laser (808 nm) was used at different powers (0.5, 1.0, and 1.5 W / cm 2) for 10 min, keeping the distance between the centrifuge tube and the laser collimator constant, and recording the temperature of the solution with a thermal imager.
[0050] The experimental results are as follows Figure 5 As shown, compared with the PBS blank group, the differently modified GNRs can quickly heat up to the platform temperature. The higher the GNRs concentration, the higher the temperature. The higher the laser power, the higher the temperature. Surface modification does not affect the photothermal conversion ability.
[0051] Example 3: In vitro cytotoxicity experiment of polyphenol-modified gold nanorods
[0052] B16-F10 cells were seeded in a 96-well plate at a density of 1000 cells per well. After culturing for 12 hours, the old culture medium was discarded. Different concentrations of the above examples were added to each well to obtain GNRs with different modifications. The control group was added with fresh culture medium without drugs. After incubation for 48 hours or 72 hours, 20 μl of 5 mg / ml MTT solution was added to each well. After further incubation for 4 hours, the old culture medium was discarded, 200 μl DMSO was added to each well to dissolve formazan, and the absorbance was measured at 490 nm using an enzyme reader. The cell inhibition rate was calculated using the formula, and the IC of each group was calculated using GraphPadPrism5.0. 50 value.
[0053] Table 1 IC of different GNRs on B16-F10 cells 50 value
[0054] The experimental results are as follows Figure 6 As shown in Table 1, CTAB is biologically toxic, IC 50 The cytotoxicity of different GNRs to B16-F10 cells was greatly reduced after surface ligand modification, and the biocompatibility was improved. 2 IC of GNR-PA and GNR-GA 50 The value is close.
[0055]
[0056] Example 4: Verification of the in vitro ICD effect of polyphenol-modified gold nanorods under light irradiation
[0057] B16-F10 cells were seeded in 24-well plates covered with 14 mm cell slides (1×10 5 cells / well) and treated with PBS or 5 μg / ml of the GNRs obtained in the above example for 4 h, and then treated with or without NIR laser (808 nm, 2 W / cm 2) irradiated the cells for 8 min. After another 4 h of incubation, the cells were washed three times with cold PBS, fixed with 4% paraformaldehyde for 10 min, and blocked with 5% BSA for 30 min. Next, the fixed cells were incubated with FITC-conjugated anti-CRT antibody (1:200) at 4°C overnight. The cell nuclei were then stained with Hoechst 33342 for 10 min at room temperature, and the fluorescence expression of the cells was observed by fluorescence confocal microscopy.
[0058] The experimental results are as follows Figure 7 As shown, GNRs can induce CRT expression only under laser irradiation, proving that the ICD effect occurs, and surface ligand modification does not affect the ability of GNRs to produce ICD effect via photothermal reaction.
[0059] Example 5: Verification of the ability of polyphenol-modified gold nanorods to capture antigens in vitro
[0060] B16-F10 melanoma cells were treated with 5 μg / ml GNRs for 4 h in 24-well plates and then heated at 2 W / cm 2 808nm laser irradiation for 8min. After removing the old culture medium and replacing it with serum-free culture medium and continuing to incubate for 48h, the supernatant was collected and centrifuged (5000rpm, 5min) twice to purify the cell phototherapy lysate. 0.5ml of cell phototherapy lysate containing TAAs was mixed with 0.5ml of GNRs with different modifications obtained in the above example at a mass ratio of 1:1, and the mixture was shaken in a 37°C incubator for 12h. The final antigen-coated GNRs with different modifications were obtained by centrifugation (13000rpm, 10min) and washing three times. The TAAs captured by GNRs were quantified by subtracting the protein concentration in the supernatant after capture from the total protein concentration. The types of captured TAAs were identified by liquid chromatography / tandem mass spectrometry (LC / MS / MS), and the data were analyzed using MaxQuant v1.5.5.1 for protein type identification.
[0061] The experimental results are as follows Figure 8 As shown, Figures A and B show the changes in particle size and potential before and after GNRs capture antigens, respectively. After successful antigen capture, the particle size increases and the potential becomes negative. Figure C shows the antigen content captured by GNRs, and GNR-GA has the strongest antigen capture ability. Figure D is a transmission electron microscope image of GNR-GA after antigen capture, and there is a clear protein mist layer on the surface of GNR-GA. Figure E is the qualitative result of mass spectrometry of antigens captured by GNR-GA, indicating that GNR-GA successfully captured new antigens and DAMPs.
[0062] Example 6: Verification of the in vitro BMDCs activation ability of antigen-coated polyphenol-modified gold nanorods
[0063] Bone marrow-derived dendritic cells (BMDCs) were isolated from the tibia and femur of C57BL / 6 mice and cultured in RPMI-1640 medium containing GM-CSF (20 ng / ml) and IL-4 (10 ng / ml) at 37°C. On day 5, cells were seeded into 24-well plates (2 × 10 6 Cells / well), and on the 7th day, 1 μg / ml of the antigen-coated GNRs with different modifications obtained in the above example were used for stimulation. After 24 h of incubation, BMDCs were collected and stained with FITC anti-mouse CD11c, APC anti-mouse CD86, and PE anti-mouse CD80 antibodies at 4°C for 40 min, and then the fluorescence intensity was detected by flow cytometry. Finally, the content of TNF-α in the supernatant was determined using a mouse TNF-α ELISA kit.
[0064] The experimental results are as follows Fig. 9 As shown, polyphenol-modified gold nanorods can effectively activate BMDCs, among which GNR-GA has the strongest activation ability, which is positively correlated with the antigen capture ability. At the same time, mature DCs can secrete more immune-related cytokine TNF-α.
[0065] Example 7: Verification of the in vivo ICD effect of polyphenol-modified gold nanorods under light irradiation
[0066] B16-F10 tumor-bearing mice were injected with 30 μg of GNRs obtained in the above examples with different modifications. After 3 h of administration, the mice were anesthetized and irradiated with or without 808 nm laser (1 W / cm 2 ) were used to irradiate the tumor for 5 min. The tumors were collected by dissection 24 h later, and the exposure of CRT and the secretion of HMGB1 were detected by immunofluorescence sectioning.
[0067] The experimental results are as follows Fig.10 As shown, compared with the PBS control group, GNRs significantly increased the CRT exposure on the cell membrane surface of tumor cells and the efflux of HMGB1 from the nucleus to the extracellular matrix after light irradiation, successfully inducing the ICD effect.
[0068] Example 8: Verification of polyphenol-modified gold nanorods inducing lymph node DCs activation in vivo
[0069] B16-F10 tumor-bearing mice were intratumorally injected with 30 μg of GNRs with different modifications obtained in the above examples and laser irradiated or not for 5 min. After 48 h, the draining lymph nodes were collected, ground and centrifuged to obtain a cell suspension, which was then stained with FITC anti-mouse CD11c, APC anti-mouse CD86, and PE anti-mouse CD80 antibodies. Finally, mature DCs were analyzed using flow cytometry.
[0070] The experimental results are as follows Fig.11 As shown, with GNR-NH2 In comparison, polyphenol-modified gold nanorods, especially GNR-GA, significantly enhanced the activation of DCs.
[0071] Example 9: Verification of the in vivo anti-tumor effect of polyphenol-modified gold nanorods
[0072] C57BL / 6 mice were injected subcutaneously on the right side with 1 × 10 6 B16-F10 cells, about 8 days later, the average tumor volume reached 80-100mm 3 The mice were divided into 5 groups (n=5): (1) PBS, (2) PBS+NIR, (3) GNR-NH 2 +NIR, (4) GNR-PA+NIR, (5) GNR-GA+NIR. Different modified GNRs were intratumorally administered, 30 μg per mouse, once every four days, for a total of two doses. Three hours after intratumoral administration, the mice were anesthetized with 808 nm laser (1 W / cm 2 ) for 5 minutes. During this period, the tumor volume and body weight were monitored every day, and the tumor volume was calculated according to the formula: volume = (long diameter × short diameter 2 ) / 2. After treatment, mice were killed and whole blood was collected for hematological toxicity testing. Tumors were dissected and weighed to calculate the tumor-bearing rate: tumor-bearing rate (%) = (m 1 / m 0 )×100, where m 1 is the tumor weight, m 0 is the weight of mice. In addition, CD8 immunofluorescence staining was performed on the tumors.
[0073] The experimental results are as follows Fig.12 As shown in Figure 2, polyphenol-modified gold nanorods significantly inhibited the growth of tumor volume, among which GNR-GA had the strongest inhibitory effect, and GNR-PA had a stronger inhibitory effect than GNR-NH 2 The final tumor-bearing rate of mice (eg Fig.13 ) was consistent with the tumor volume growth trend, demonstrating that the polyphenol-captured antigen strategy can enhance the tumor inhibition effect of photothermal therapy by protecting TAAs.
[0074] By analyzing the changes in body weight of tumor-bearing mice (such as Fig.14 ) and changes in blood indicators (such as Fig.15 ) was used to evaluate the safety of polyphenol-modified gold nanorods. The results showed that there was no significant decrease in body weight of mice in each group, and there were no significant differences in blood indicators compared with the PBS group, proving that the treatment regimen has good safety.
[0075] The immune cell infiltration of tumors was observed by CD8 immunofluorescence staining of mouse tumor sections. Fig.16 As shown, compared with the PBS group, GNR-NH2 The GNR-PA group had fewer CD8 + T cell infiltration, the GNR-GA group significantly increased CD8 + The content of T cells indicated that the in situ antigen capture strategy successfully activated the immune response.
[0076] In summary, the present invention prepares uniform and stable polyphenol-modified gold nanorods with antigen capture ability. The surface ligand modification does not affect the photothermal conversion ability of the gold nanorods. Photothermal therapy kills tumor cells while inducing the ICD effect to release TAAs. Antigens can be successfully captured by polyphenols on the surface of gold nanorods, reducing rapid immune clearance. The results show that compared with GNR-NH 2 In comparison, GNR-PA and GNR-GA have stronger antigen capture ability. Based on the fact that polyphenols mainly bind to antigens through interactions such as hydrogen bonds, since the phenolic hydroxyl content of GNR-PA is lower than that of GNR-GA, its antigen capture ability is weaker than that of GNR-GA. Correspondingly, the in vivo efficacy results also show that the anti-tumor effect and immune activation ability of GNR-PA are weaker than those of GNR-GA. These results show that the antigen capture ability of polyphenol-modified gold nanorods with antigen capture ability is positively correlated with the phenolic hydroxyl content, and the antigen capture ability can be further enhanced by increasing the modification amount of phenolic hydroxyl groups.
Claims
1. A method for preparing polyphenol-modified gold nanorods with antigen capture capability, characterized in that: The polyphenol-modified gold nanorods are based on gold nanorods, which are ligand-exchanged with HS-PEG-NH2 via gold-sulfur bonds, and then connected to polyphenols via amide bonds to obtain polyphenol-modified gold nanorods.
2. The method for preparing polyphenol-modified gold nanorods with antigen capture ability according to claim 1, characterized in that: (1) Ligand exchange of gold nanorods: prepare an aqueous solution of HS-PEG-NH2, slowly add it to the gold nanorod solution, keep stirring in the dark, fully centrifuge after the reaction is completed, and resuspend in PBS buffer to obtain PEG-stabilized gold nanorods; (2) Covalent attachment of polyphenols: Dissolve polyphenols, EDCI and NHS in MES buffer, stir under ice bath to activate the carboxyl groups on the polyphenols, then add them to the modified gold nanorods solution and stir at room temperature. After the reaction, centrifuge thoroughly and resuspend in PBS buffer to obtain polyphenol-modified gold nanorods.
3. The method for preparing polyphenol-modified gold nanorods with antigen capture ability according to claim 2, characterized in that: The absorption peak of the gold nanorod is located in at least one of the visible light region, the near infrared region I and the near infrared region II.
4. The method for preparing polyphenol-modified gold nanorods with antigen capture capability according to claim 3, characterized in that: The gold nanorods are prepared by preparing gold seeds and a growth solution through a classic seed growth method, dripping the gold seed solution into the growth solution while stirring, incubating overnight in the dark, fully centrifuging after the reaction is completed, resuspending with deionized water, removing excess surfactant hexadecyltrimethylammonium bromide (CTAB) and other reactants, and obtaining a gold nanorod solution.
5. The method for preparing polyphenol-modified gold nanorods with antigen capture ability according to claim 2, characterized in that: In the step (1), the aqueous solution of HS-PEG-NH2 and the gold nanorod solution are mixed at a molar ratio of 200:1-20000:1, reacted at room temperature for 12 hours, and fully centrifuged and resuspended with PBS buffer after the reaction, and the process is repeated several times to remove the unreacted residues to obtain PEG-stabilized gold nanorods; wherein the centrifugation conditions are: 13000 rpm, 10 min.
6. The method for preparing polyphenol-modified gold nanorods with antigen capture capability according to claim 2 or 5, characterized in that: The HS-PEG-NH2 connecting chain is HS-PEG 600 -NH2, HS-PEG 2000 -NH2, HS-PEG 5000 -NH2, HS-PEG 20000 -NH2 one or more.
7. The method for preparing polyphenol-modified gold nanorods with antigen capture capability according to claim 2, characterized in that: In the step (2), polyphenols, EDCI and NHS are mixed and dissolved in a MES buffer at a molar ratio of 5:1:1-0.5:1:1; the pH of the MES buffer is 4.5-7.2; and the molar ratio of gold nanorods to polyphenols is 1:200-1:20000.
8. The method for preparing polyphenol-modified gold nanorods with antigen-capturing ability according to claim 2 or 7, characterized in that: The polyphenols are phenolic acid compounds; wherein the phenolic acid compounds are caffeic acid, p-coumaric acid, ferulic acid, sinapinic acid, rosmarinic acid, 4-hydroxyphenylacetic acid, 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 3,4,5-trihydroxybenzoic acid and 3,4-dihydroxyphenylacetic acid.
9. A polyphenol-modified gold nanorod with antigen-capturing ability prepared by the method of claim 1, characterized in that: The polyphenol-modified gold nanorods with antigen-capturing ability and uniform dispersion having a long diameter of 30-40 nm and a short diameter of 3-4 nm are prepared according to the method of claim 1.
10. Use of the polyphenol-modified gold nanorods with antigen-capturing ability according to claim 9 in preparing a drug delivery system or an anti-tumor drug.
Citation Information
Patent Citations
Target PEG (Polyethylene Glycol) modified gold nanorod and AlpcS4 coupled combination as well as preparation, application and antitumor composition thereof
CN107469081A
Gold nanomaterial / carbon quantum dot composite plasma fluorescent nanoprobe as well as preparation method and application thereof
CN115806815A
Chemical kinetics anti-tumor nanoparticles as well as preparation method and application thereof
CN117257983A
Antigen capture nanoparticle and application of preparation method thereof in tumor immunotherapy
CN117883556A
Preparation and application of gold nanorod and lipidosome thereof
CN118320090A
Cited By
Preparation method and application of rapid and controllable large-scale gold nanorod silicon-coated material
CN120394890A
